Since GPR40 and GPR120 are sensors of and modulate responses to a variety of ω-3 and ω-6 PUFA-derived lipid mediators, these receptors likely mediate divergent outcomes in human cancers, as shown in CRC [137]. This evidence concerns the gene FFAR4 and cancer.